Apr 7 2010
Orchid Cellmark Inc. (Nasdaq:ORCH), a leading international provider of identity DNA testing services, today announced it has acquired the paternity and immigration DNA testing business unit of Strand Analytical Laboratories, LLC.
Strand is a provider of forensic, medical, and paternity DNA testing services based in Indianapolis, Indiana.
Under terms of the contract, which were not disclosed, Orchid Cellmark will acquire the government paternity, private paternity, and immigration testing accounts of Strand. In 2009, Strand's paternity and immigration testing business unit had revenue of approximately $450,000. Strand will continue to service the clients of its other DNA testing business units.
"While Strand's paternity business is relatively small in size, the acquisition is consistent with our strategy to grow revenues," said Thomas Bologna, president and chief executive officer of Orchid Cellmark. "With virtually no customer overlap, Strand's paternity and immigration laboratory testing businesses fit well into our operations and will be serviced from our paternity facility in Dayton, Ohio," he added.
SOURCE Orchid Cellmark Inc.